Isomorphic Labs

United Kingdom - London

• 01/04/2025
• Unknown
• $600,000,000

Isomorphic Labs is a new Alphabet company and commercial venture which aims to reimagine the entire drug discovery process from first principles with an AI-first approach, and, ultimately, to model and understand some of the fundamental mechanisms of life.

Using computational advances, we’re working at the cutting edge in the new era of ‘digital biology’. By significantly increasing the pace of scientific research and efficacy of new medicines, we will be at the forefront of breakthroughs that will benefit millions of people.

Related People

Demis HassabisFounder

United Kingdom - Greater London, England

Co-Founder & CEO of Google DeepMind - working on AGI, responsible for AI breakthroughs such as AlphaGo, the first program to beat the world champion at the game of Go; and AlphaFold, which cracked the 50-year grand challenge of protein structure prediction and was recognised with the 2024 Nobel Prize in Chemistry. Revolutionising drug discovery at Isomorphic Labs. Ultimately trying to understand the fundamental nature of reality.

LinkedIn https://www.linkedin.com/in/demishassabis/